MicroViable Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 3

MicroViable Therapeutics General Information

Description

Developer of a microbiota-based therapeutics platform intended to store and preserve intestinal microbiota. The company's therapeutics specializes in microbiota kits designed to keep the anaerobic conditions of stool samples during the process of sample collection and transport, creating the desired environment for the intestinal microbes to survive, enabling healthcare professionals to collect samples following protocols and procedures in stool collection without the need to freeze samples.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Calle Los Prados, 166
  • Impulsa Building. Scientific Park
  • 33203 Gijón
  • Spain
+34 984
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Calle Los Prados, 166
  • Impulsa Building. Scientific Park
  • 33203 Gijón
  • Spain
+34 984

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MicroViable Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Dec-2024 Completed Pre-Clinical Trials
4. Later Stage VC 06-Sep-2023 Cancelled Pre-Clinical Trials
3. Later Stage VC 21-Apr-2022 Completed Pre-Clinical Trials
2. Later Stage VC 29-Jul-2021 $236K $353K Completed Startup
1. Angel (individual) 01-Oct-2018 $117K $117K Completed Startup
To view MicroViable Therapeutics’s complete valuation and funding history, request access »

MicroViable Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 1,040 $1.093259 $52.55 $52.55 1x $52.55 3.26%
Ordinary 5,000 $1.093259 $21.87 $21.87 1x $21.87 15.68%
To view MicroViable Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

MicroViable Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a microbiota-based therapeutics platform intended to store and preserve intestinal microbiota. The company'
Drug Discovery
Gijón, Spain
19 As of 2026

Paris, France
 

Lyon, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MicroViable Therapeutics Competitors (4)

One of MicroViable Therapeutics’s 4 competitors is Enterome, a Venture Capital-Backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Enterome Venture Capital-Backed Paris, France
MaaT Pharma Formerly VC-backed Lyon, France
Biose Industrie Private Equity-Backed Aurillac, France
Natur's Way Probiotics Corporation Horton, KS
To view MicroViable Therapeutics’s complete competitors history, request access »

MicroViable Therapeutics Patents

MicroViable Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4606380-A1 Method for fecal microbiome purification and uses thereof Inactive 22-Feb-2024
EP-4630020-A1 Method for fecal microbiome purification and uses thereof Active 22-Feb-2024
EP-4630020-B1 Method for fecal microbiome purification and uses thereof Active 22-Feb-2024
EP-4630020-C0 Method for fecal microbiome purification and uses thereof Active 22-Feb-2024
WO-2025141228-A1 Method for fecal microbiome purification and uses thereof Pending 22-Feb-2024 A61K35/37
To view MicroViable Therapeutics’s complete patent history, request access »

MicroViable Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MicroViable Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Corporación Alimentaria Peñasanta (Spanish) Corporate Venture Capital Minority
Inmunomet Corporation Minority
PADEInvest Group Venture Capital Minority
To view MicroViable Therapeutics’s complete investors history, request access »

MicroViable Therapeutics FAQs

  • When was MicroViable Therapeutics founded?

    MicroViable Therapeutics was founded in 2016.

  • Where is MicroViable Therapeutics headquartered?

    MicroViable Therapeutics is headquartered in Gijón, Spain.

  • What is the size of MicroViable Therapeutics?

    MicroViable Therapeutics has 19 total employees.

  • What industry is MicroViable Therapeutics in?

    MicroViable Therapeutics’s primary industry is Drug Discovery.

  • Is MicroViable Therapeutics a private or public company?

    MicroViable Therapeutics is a Private company.

  • What is MicroViable Therapeutics’s current revenue?

    The current revenue for MicroViable Therapeutics is .

  • How much funding has MicroViable Therapeutics raised over time?

    MicroViable Therapeutics has raised $1.98M.

  • Who are MicroViable Therapeutics’s investors?

    Corporación Alimentaria Peñasanta (Spanish), Inmunomet, and PADEInvest Group have invested in MicroViable Therapeutics.

  • Who are MicroViable Therapeutics’s competitors?

    Enterome, MaaT Pharma, Biose Industrie, and Natur's Way Probiotics are competitors of MicroViable Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process